Literature DB >> 20878042

Myotonic dystrophy: the burden for patients and their partners.

Reinier Timman1, Aad Tibben, Axel R Wintzen.   

Abstract

OBJECTIVE: Dystrophia myotonica is characterized by progressive muscular weakness, myotonia, mental slowness and lack of initiative, which causes problems in daily life both for patients and for their spouses. Some couples seem to deal with these problems satisfactorily, while for others they are quite burdensome. The aim of this study was to describe the relationship of severity of dystrophia myotonica and psychological wellbeing in patients and partners.
METHODS: Sixty-nine couples, in whom one partner had dystrophia myotonica, completed questionnaires on severity of dystrophia myotonica, marital satisfaction, anxiety and depression (Hospital Anxiety and Depression Scale), hopelessness (Beck Hopelessness Scale) and general psychological health (General Health Questionnaire-12).
RESULTS: For patients, a worse view of the future, worse general wellbeing, more anxiety and more depression was associated with a greater need for help. For partners, worse general wellbeing and more anxiety was associated with a lack of initiative of the patient and less marital satisfaction. It is noteworthy that 40% of patients and particularly female partners had Beck Hopelessness Scale scores suggestive of clinically relevant depression.
CONCLUSION: Dystrophia myotonica places a heavy burden on patients, and especially on female partners. The need for help and dependency has more influence on the wellbeing of patients than the symptoms of dystrophia myotonica themselves. Marital satisfaction is a strong predictor of better wellbeing, both for patients and, even more so, for partners.

Entities:  

Mesh:

Year:  2010        PMID: 20878042     DOI: 10.2340/16501977-0598

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  6 in total

1.  Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).

Authors:  Chad Heatwole; Rita Bode; Nicholas Johnson; Christine Quinn; William Martens; Michael P McDermott; Nan Rothrock; Charles Thornton; Barbara Vickrey; David Victorson; Richard Moxley
Journal:  Neurology       Date:  2012-07-11       Impact factor: 9.910

2.  Effects of shared medical appointments on quality of life and cost-effectiveness for patients with a chronic neuromuscular disease. Study protocol of a randomized controlled trial.

Authors:  Femke M Seesing; Gea Drost; Gert-Jan van der Wilt; Baziel G M van Engelen
Journal:  BMC Neurol       Date:  2011-08-23       Impact factor: 2.474

3.  Living with myotonic dystrophy; what can be learned from couples? A qualitative study.

Authors:  Edith H C Cup; Astrid Kinébanian; Ton Satink; Allan J Pieterse; Henk T Hendricks; Rob A B Oostendorp; Gert Jan van der Wilt; Baziel G M van Engelen
Journal:  BMC Neurol       Date:  2011-07-13       Impact factor: 2.474

4.  Understanding the experience of myotonic dystrophy. Mixed method study.

Authors:  Amy Østertun Geirdal; Inger Lund-Petersen; Arvid Heiberg
Journal:  J Genet Couns       Date:  2014-08-16       Impact factor: 2.537

Review 5.  A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Authors:  Lisa Minier; Baptiste Lignier; Cyrille Bouvet; Benjamin Gallais; Nathalie Camart
Journal:  J Neuromuscul Dis       Date:  2018

6.  Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.

Authors:  Ann-Marie Chapman; Marieke Schurer; Laure Weijers; Amer Omar; Hiba Lee; Alla Zozulya Weidenfeller; Crispin Ellis; Shaneil Sonecha; Christiane Schneider-Gold
Journal:  BMC Neurol       Date:  2021-12-01       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.